XMRV virus may cause prostate cancer in people

Researchers find first evidence of virus in malignant prostate cells in prostate cancer — XMRV retrovirus is associated with more aggressive tumors of prostate gland. – XMRV (Xenotropic murine leukemia virus-related virus) — a type of virus known to cause leukemia and sarcomas in animals has been found for the first time in malignant human prostate cancer cells.

TNF blockers will have boxed warning cancer risk

FDA: Cancer Warnings Required for TNF Blockers – The U.S. Food and Drug Administration is requiring stronger warnings in the prescribing information for a class of drugs known as TNF blockers or TNF inhibitors.

Agent Orange exposure linked to heart disease and Parkinson’s disease

Limited data suggest possible association between Agent Orange exposure – A new report from the Institute of Medicine finds suggestive but limited evidence that exposure to Agent Orange and other herbicides used during the Vietnam War is associated with an increased chance of developing ischemic heart disease and Parkinson’s disease for Vietnam veterans.

Stem cell protein LIN28 offers a new cancer target

LIN28, which maintains cell ‘stemness,’ is abundant in advanced cancers and transforms cells to cancerous state – A protein abundant in embryonic stem cells is now shown to be important in cancer, and offers a possible new target for drug development, report researchers from the Stem Cell Program at Children’s Hospital Boston.

GenWay Biotech distributor of AMDL’s DR-70 cancer test in US and Canada

GenWay Biotech obtains exclusive rights to AMDL’s DR-70 cancer test in US and Canada. AMDL Inc. executes two exclusive distribution agreements for cancer test with GenWay Biotech Inc. – GenWay Biotech, Inc., a US-based diagnostic company which specializes in providing protein and antibody solutions, announced its partnership with AMDL, Inc., a US-based pharmaceutical company with major operations in China, regarding the distribution of AMDL’s DR-70 (FDP) cancer test in both the United States and Canada.

Wine increases survival in Non Hodgkin’s lymphoma patients

Drinking wine may increase survival among non-Hodgkin’s lymphoma patients. – Pre-diagnostic wine consumption may reduce the risk of death and relapse among non-Hodgkin’s lymphoma patients, according to an epidemiology study presented at the American Association for Cancer Research 100th Annual Meeting 2009.

A tiny drop of blood helps to assess cancer details

New alternative to biopsy detects subtle changes in cancer cells, Stanford study shows. – A drop of blood or a chunk of tissue smaller than the period at the end of this sentence may one day be all that is necessary to diagnose cancers and assess their response to treatment, say researchers at the Stanford University School of Medicine.

Grape seed extract may cure leukemia

Grape seed extract kills laboratory leukemia cells, proving value of natural compounds. – An extract from grape seeds forces laboratory leukemia cells to commit cell suicide, according to researchers from the University of Kentucky. They found that within 24 hours, 76 percent of leukemia cells had died after being exposed to the extract.

A universal mechanism of aging is identified

New evidence may explain why it is that we lose not only our youthful looks, but also our youthful pattern of gene activity with age. – Researchers have discovered that DNA damage decreases a cell’s ability to regulate which genes are turned on and off in particular settings. This mechanism, which applies both to fungus and to us, might represent a universal culprit for aging.

New genes identified linked to lung cancer

Scientists find new genes linked to lung cancer. Discovery opens door to individualized treatment strategies. – Working as part of a multi-institutional collaboration, scientists at Washington University School of Medicine in St. Louis have assembled the most complete catalog to date of the genetic changes underlying the most common form of lung cancer.

Health Newstrack